Company Cash Funds: XOMA Corp (XOMA)

Official company branding of XOMA Royalty (XOMA)

XOMA Royalty (XOMA) revenues depend on the results of third-party tests and patent expiration dates. The cash flow history demonstrates a pivot driven by the acquisition of rights to early-stage drugs and the absence of R&D expenses, which maximizes margins. The current liquidity level 0.10 shows the current value of the metric, confirming the business's financial stability under passive asset management.

XOMA - XOMA Royalty Corporation Company Cash Volume over the range 07/04/2022 - 07/25/2026

Financial and market metric breakdowns for xoma.com (XOMA)

- stock value and consensus price forecast:
- company stock exchange capitalization indicators:
Analysis of all company metrics:XOMA Royalty Corporation XOMA
Signature product of XOMA Royalty

This metric measures the total volume of liquid assets, determining the issuer's ability to service obligations without seeking external financing. For XOMA Royalty (XOMA), maintaining reserves is critical during the aggressive acquisition of rights to various biotechnological drugs. By analyzing the cash on hand, an investor assesses the sustainability of the royalty portfolio diversification strategy. High liquidity minimizes default risk, confirming the asset's conservative safety profile.